Abstract
DNA and RNA regions containing tracts of guanines can form very stable secondary structures called G-quadruplex (G4). Genomic sequences with the potential to form G4 (G4-motifs) are abundant across species. In all analyzed genomes G4 motifs are found near promoter regions and double strand break sites and at telomeres. Telomeres are very G-rich and prone for G4 formation. Therefore they are routinely used in in vitro and in vivo experiments to elucidate the function of G4 structures in telomere metabolism. Recently various labs demonstrated that telomere length maintenance is mediated via G4 structures. Telomere-binding proteins specifically bind to G4 structure and regulate this structure throughout the cell cycle.
Keywords: Ciliate, helicase, higher-order DNA structure, telomere-binding protein, genomes, chromosomal ends, DNA replication, intronic splicing, TEBPβ, phosphorylation
Current Pharmaceutical Design
Title:Cell Cycle Regulation of G-Quadruplex DNA Structures at Telomeres
Volume: 18 Issue: 14
Author(s): Stefan A. Juranek and Katrin Paeschke
Affiliation:
Keywords: Ciliate, helicase, higher-order DNA structure, telomere-binding protein, genomes, chromosomal ends, DNA replication, intronic splicing, TEBPβ, phosphorylation
Abstract: DNA and RNA regions containing tracts of guanines can form very stable secondary structures called G-quadruplex (G4). Genomic sequences with the potential to form G4 (G4-motifs) are abundant across species. In all analyzed genomes G4 motifs are found near promoter regions and double strand break sites and at telomeres. Telomeres are very G-rich and prone for G4 formation. Therefore they are routinely used in in vitro and in vivo experiments to elucidate the function of G4 structures in telomere metabolism. Recently various labs demonstrated that telomere length maintenance is mediated via G4 structures. Telomere-binding proteins specifically bind to G4 structure and regulate this structure throughout the cell cycle.
Export Options
About this article
Cite this article as:
A. Juranek Stefan and Paeschke Katrin, Cell Cycle Regulation of G-Quadruplex DNA Structures at Telomeres, Current Pharmaceutical Design 2012; 18 (14) . https://dx.doi.org/10.2174/138161212799958404
DOI https://dx.doi.org/10.2174/138161212799958404 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
Current Medicinal Chemistry The Role of Melatonin in Pancreatic Protection: Could Melatonin be Used in the Treatment of Acute Pancreatitis?
Current Pharmaceutical Design Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
Current Pharmaceutical Design Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges
Current Diabetes Reviews Bioinformatic Analysis of HIV-1 Entry and Pathogenesis
Current HIV Research New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry Melatonin, Autophagy and Intestinal Bowel Disease
Current Pharmaceutical Design Iodinated Contrast Media in Diagnostic Imaging: Cardiovascular Side Effects
Current Pharmacogenomics and Personalized Medicine Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy
Current Gene Therapy Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Current Medicinal Chemistry Development of HIV-1 Fusion Inhibitors Targeting gp41
Current Medicinal Chemistry Novel Prodrugs for the Treatment of Colonic Diseases Based on 5-Aminosalicylic Acid, 4'-eranyloxyferulic Acid, and Auraptene: Biological Activities and Analytical Assays
Current Drug Delivery B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Tangy Scent in Toona sinensis (Meliaceae) Leaflets: Isolation, Functional Characterization, and Regulation of TsTPS1 and TsTPS2, Two Key Terpene Synthase Genes in the Biosynthesis of the Scent Compound
Current Pharmaceutical Biotechnology Protease Inhibitors with Antileishmanial Activity
Current Enzyme Inhibition The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer’s Disease
Current Pharmaceutical Design Treatment of Opportunistic Infections Prior to HAART Initiation Does Not Affect Immune Reconstitution in HIV-Infected Patients
Current HIV Research Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population
Drug Metabolism Letters Pharmacokinetic Considerations of Perinatal Antiretroviral Therapy
Current Drug Metabolism